HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laboratory and clinical study of balofloxacin (Q-35), a new fluoroquinolone, in urinary tract infection.

AuthorsK Suzuki, M Horiba, K Ishikawa, S Katoh, Y Naide, M Yanaoka, S Andoh
JournalDrugs (Drugs) Vol. 49 Suppl 2 Pg. 376-8 ( 1995) ISSN: 0012-6667 [Print] New Zealand
PMID8549367 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Anti-Infective Agents
  • Fluoroquinolones
  • Quinolones
  • balofloxacin
Topics
  • Anti-Infective Agents (adverse effects, pharmacokinetics, therapeutic use)
  • Diffusion
  • Enterococcus faecalis (drug effects)
  • Female
  • Fluoroquinolones
  • Humans
  • Male
  • Prostate (metabolism)
  • Quinolones (adverse effects, pharmacokinetics, therapeutic use)
  • Serum Bactericidal Test
  • Urinary Tract Infections (complications, drug therapy, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: